Cervical Cancer Working Group Report

Concurrent Infection with Multiple Human Papillomavirus Types: Pooled Analysis of the IARC HPV Prevalence Surveys

(2010) S. Vaccarella et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Cost-Effectiveness Analysis of Prophylactic Cervical Cancer Vaccination in Japanese Women

(2010) Ryo Konno et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Human papillomavirus infections among Japanese women: age-related prevalence and type-specific risk for cervical cancer

(2009) Mamiko Onuki et al.   CANCER SCIENCE

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

(2009) J Paavonen et al.   LANCET

A review of human carcinogens—Part B: biological agents

(2009) Véronique Bouvard et al.   LANCET ONCOLOGY

WHO position on HPV vaccines

(2009)   VACCINE

Awareness of and attitude towards human papillomavirus infection and vaccination for cervical cancer prevention among adult males and females in Korea: A nationwide interview survey

(2009) Jin-Kyoung Oh et al.   VACCINE

The predicted impact of vaccination on human papillomavirus infections in Australia

(2008) Megan A. Smith et al.   INTERNATIONAL JOURNAL OF CANCER